Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexey Shevchuk
Hertzen Institute, Moscow
Study Chair - Brynhildur Eyjolfsdottir
Oslo University Hospital
Study Chair - Christian Marth
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
Study Chair - Cor de Kroon
The Dutch Gynecological Oncology Group (DGOG)
Study Chair - Frederic Goffin
Belgian Gynaecological Oncology Group
Study Chair - Gwenael Ferron
France-GINECO
Study Chair - Jae-Weon Kim
Korean Gynecology Oncology Group
Study Chair - John Tidy
Institute of Cancer Research, United Kingdom
Study Chair - Marie Plante
Canadian Cancer Trials Group
Study Chair - Noreen Gleeson
Ireland Co-operative Oncology Research Group
Study Chair - Sven Mahner
AGO Germany
Study Chair - Xiaohua Wu
Fudan University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Barmherzige Brueder Graz
Graz, Austria
- Medical University of Graz
Graz, Austria
- Medical University of Innsbruck
Innsbruck, Austria
- Lkh Leoben
Leoben, Austria
- Landes- Frauen- Und Kinderklinik Linz
Linz, Austria
- Lkh Salzburg
Salzburg, Austria
- Medical University of Vienna
Vienna, Austria
- Uz Leuven
Leuven, Vlaams-Brabant, Belgium
- Chr de la Citadelle Liege
Liège, Belgium
- Chu Sart Tilman Liege
Liège, Belgium
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Clinical Research Unit at Vancouver Coastal
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Qeii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Regional Health Centre
Barrie, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Trillium Health Partners - Credit Valley Hospital
Mississauga, Ontario, Canada
- Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
- University Health Network
Toronto, Ontario, Canada
- Facility name not stated
Greenfield Park, Quebec, Canada
- Chum-Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Ciusss de L'Est-de-I'Lle-de-Montreal
Montreal, Quebec, Canada
- the Jewish General Hospital
Montreal, Quebec, Canada
- Facility name not stated
Québec, Quebec, Canada
- Ciusss de L'Estrie - Centre Hospitalier
Sherbrooke, Quebec, Canada
- Shanghai Cancer Center
Shanghai, China
- Chu Amiens
Amiens, France
- Institut Bergonie Bordeaux
Bordeaux, France
- Chru de Brest
Brest, France
- Chu de Chambery
Chambéry, France
- Chu de Clermont-Ferrand
Clermont-Ferrand, France
- Centre Jean Perrin - Clermont-Ferrand
Clermont-Ferrand, France
- Chu de Dijon
Dijon, France
- Centre Georges Francois Leclerc - Dijon
Dijon, France
- Chru de Lille
Lille, France
- Centre Oscar Lambret - Lille
Lille, France
- Chu Limoges
Limoges, France
- Centre Leon Berard - Lyon
Lyon, France
- Hospices Civils de Lyon
Lyon, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Dec 2012
- Primary completion
- 11 Mar 2023
- Completion
- 4 Nov 2024
- Last update posted
- 17 Dec 2024
- Registered enrollment
- 700
- Registry id
- NCT01658930
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.